Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report

Autor:	Antonio Waldo Zuardi, Ila M. P. Linares, Danielle Chaves Gomes de Oliveira, Mateus M. Bergamaschi, Regina Helena Costa Queiroz, Maria Eugênia Costa Queiroz, Marcos Hortes Nisihara Chagas, Fabrício A. Moreira, Marilyn A. Huestis, José Alexandre de Souza Crippa, Kátia C. Arrais, Antonio Egidio Nardi, Jaime Eduardo Cecílio Hallak
Rok vydání:	2013
Předmět:	medicine.medical_specialty Cannabinoid receptor medicine.medical_treatment Antagonist Audiology Pharmacology Psychiatry and Mental health Public speaking Neurology Rimonabant medicine Cannabinoid receptor antagonist Inverse agonist Anxiety Pharmacology (medical) Neurology (clinical) Cannabinoid medicine.symptom Psychology medicine.drug
Zdroj:	Human Psychopharmacology: Clinical and Experimental. 29:94-99
ISSN:	0885-6222
DOI:	10.1002/hup.2374
Popis:	Objective We investigated the hypothesis that rimonabant, a cannabinoid antagonist/inverse agonist, would increase anxiety in healthy subjects during a simulation of the public speaking test.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::053c9154e62a38aa5da84f11ed5288c3 https://doi.org/10.1002/hup.2374 Zobrazit plný text záznamu Plný text